The risk of coronary heart disease in patients with kidney stones: A systematic review and meta-analysis

North American Journal of Medical Sciences

Volumn 6, Issue 11, 2014, Pages 580-585

  Cheungpasitporn, Wisit ^a   Thongprayoon, Charat ^a   Mao, Michael A ^a   O'Corragain, Oisin A ^b   Edmonds, Peter J ^c   Erickson, Stephen B ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Cardiovascular; Gender; Nephrolithiasis

Indexed keywords

ARTICLE; DISEASE ASSOCIATION; HAZARD RATIO; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; NEPHROLITHIASIS; PUBLISHING; RISK; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW (TOPIC);

EID: 84912096775     PISSN: 22501541     EISSN: 19472714     Source Type: Journal    
DOI: 10.4103/1947-2714.145477     Document Type: Article

References (28)

1. Goldfarb DS. Kidney stones and the risk of coronary heart disease. Am J Kidney Dis 2013;62:1039-41.
2. Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Samuel S, Klarenbach SW, et al. Kidney stones and cardiovascular events: A cohort study. Clin J Am Soc Nephrol 2014;9:506-12.
3. Ando R, Nagaya T, Suzuki S, Takahashi H, Kawai M, Okada A, et al. Kidney stone formation is positively associated with conventional risk factors for coronary heart disease in Japanese men. J Urol 2013;189:1340-6.
4. Domingos F, Serra A. Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant 2011;26:864-8.
5. Hamano S, Nakatsu H, Suzuki N, Tomioka S, Tanaka M, Murakami S. Kidney stone disease and risk factors for coronary heart disease. Int J Urol 2005;12:859-63.
6. Linden V. Vitamin D and myocardial infarction. Br Med J 1974;3:647-50.
7. Rule AD, Roger VL, Melton LJ 3rd, Bergstralh EJ, Li X, Peyser PA, et al. Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol 2010;21:1641-4.
8. Zimmerer T, Weiss C, Hammes HP, Braun C, Hesse A, Alken P, et al. Evaluation of urolithiasis: A link between stone formation and diabetes mellitus? Urol Int 2009;82:350-5.
9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
10. Stang A. Critical evaluation of the newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603-5.
11. Westlund K. Urolithiasis and coronary heart disease: A note on association. Am J Epidemiol 1973;97:167-72.
12. Tang J, Mettler P, McFann K, Chonchol M. The association of prevalent kidney stone disease with mortality in us adults: The national health and nutrition examination survey III, 1988-1994. Am J Nephrol 2013;37:501-6.
13. Elmfeldt D, Vedin A, Wilhelmsson C, Tibblin G, Wilhelmsen L. Morbidity in representative male survivors of myocardial infarction compared to representative population samples. J Chronic Dis 1976;29:221-31.
14. Ferraro PM, Taylor EN, Eisner BH, Gambaro G, Rimm EB, Mukamal KJ, et al. History of kidney stones and the risk of coronary heart disease. JAMA 2013;310:408-15.
15. Ungprasert P, Wannarong T, Panichsillapakit T, Cheungpasitporn W, Thongprayoon C, Ahmed S, et al. Cardiac involvement in mixed connective tissue disease: A systematic review. Int J Cardiol 2014;171:326-30.
16. Ungprasert P, Charoenpong P, Ratanasrimetha P, Thongprayoon C, Cheungpasitporn W, Suksaranjit P. Risk of coronary artery disease in patients with systemic sclerosis: A systematic review and meta-analysis. Clin Rheumatol 2014;33:1099-104.
17. Ungprasert P, Srivali N, Wijarnpreecha K, Thongprayoon C, Cheungpasitporn W, Knight EL. Is the incidence of malignancy increased in patients with sarcoidosis? A systematic review and meta-analysis. Respirology 2014;19:993-8.
18. Cheungpasitporn W, Thongprayoon C, O'Corragain OA, Edmonds PJ, Ungprasert P, Kittanamongkolchai W, et al. The risk of kidney cancer in patients with kidney stones: A systematic review and meta-analysis. QJM 2014.
19. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
20. Sakhaee K. Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens 2008;17:304-9.
21. Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 2005;68:1230-5.
22. Cameron MA, Maalouf NM, Adams-Huet B, Moe OW, Sakhaee K. Urine composition in type 2 diabetes: Predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 2006;17:1422-8.
23. Schwille PO, Schmiedl A, Herrmann U, Wipplinger J. Postprandial hyperinsulinaemia, insulin resistance and inappropriately high phosphaturia are features of younger males with idiopathic calcium urolithiasis: Attenuation by ascorbic acid supplementation of a test meal. Urol Res 1997;25:49-58.
24. Khan SR, Rodriguez DE, Gower LB, Monga M. Association of Randall plaque with collagen fibers and membrane vesicles. J Urol 2012;187:1094-100.
25. Schlieper G, Westenfeld R, Brandenburg V, Ketteler M. Inhibitors of calcification in blood and urine. Semin Dial 2007;20:113-21.
26. Scales CD Jr, Smith AC, Hanley JM, Saigal CS; Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol 2012;62:160-5.
27. Centers for Disease Control and Prevention (CDC). Prevalence of coronary heart disease--United States, 2006-2010. MMWR Morb Mortal Wkly Rep 2011;60:1377-81.
28. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 1997;126:497-504.